WEBULL

Gildan Activewear (TSX:GIL) Is Down 8.1% After Short Seller, Law Firm Scrutinize Reported Growth Quality

Simply Wall St · 2d ago
  • In July 2026, Rosen Law Firm began investigating potential securities claims on behalf of Gildan Activewear shareholders after a Jehoshaphat Research short seller report alleged the company issued materially misleading information and masked negative organic growth through financial engineering.
  • This legal and research scrutiny raises questions about the quality and transparency of Gildan’s reported business performance, which may influence how investors assess its underlying fundamentals.
  • We’ll now examine how this shareholder investigation and the negative organic growth allegations could affect Gildan Activewear’s previously optimistic investment narrative.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Gildan Activewear Investment Narrative Recap

To own Gildan today, you need to believe its vertically integrated model and focus on value basics can still support resilient earnings, even after a weak first quarter and a recent swing to losses. The Jehoshaphat short report and Rosen Law Firm inquiry directly challenge the reliability of Gildan’s reported growth, which now looms as the key near term risk and may overshadow near term benefits from new programs and cost efficiencies if confidence in the numbers deteriorates.

Against this backdrop, Gildan’s February 2026 move to raise its quarterly dividend by 10% and then reaffirm that payout in April is particularly relevant. These actions signal management’s willingness to continue returning cash to shareholders despite recent earnings pressure and the subsequent investigation, which some investors may weigh against concerns about organic growth, quality of earnings and the sustainability of capital returns if scrutiny intensifies.

Yet while bullish analysts once projected revenue of about US$7.3 billion and earnings of roughly US$1.3 billion by 2029, you should now consider how allegations about negative organic growth and financial engineering might challenge those assumptions and what that could mean for Gildan’s most important risk that investors should be aware of...

Read the full narrative on Gildan Activewear (it's free!)

Gildan Activewear's narrative projects $6.9 billion revenue and $1.2 billion earnings by 2029. This requires 19.0% yearly revenue growth and about a $945.8 million earnings increase from $254.2 million today.

Uncover how Gildan Activewear's forecasts yield a CA$106.82 fair value, a 52% upside to its current price.

Exploring Other Perspectives

TSX:GIL 1-Year Stock Price Chart
TSX:GIL 1-Year Stock Price Chart

Before this scrutiny, the most optimistic analysts saw Gildan’s earnings climbing toward about US$1.3 billion by 2029, but if ESG and transparency concerns grow, that upbeat outlook could diverge sharply from how you judge the stock’s risk and reward today.

Explore 4 other fair value estimates on Gildan Activewear - why the stock might be worth over 2x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Ready For A Different Approach?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.